Wednesday, September 21, 2005 12:18:52 PM
Wed Sep 21, 2005 11:51 AM ET
(Adds FDA, analyst comments, byline; updates share prices)
By Susan Heavey
WASHINGTON, Sept 21 (Reuters) - U.S. regulators granted conditional approval to a second maker of silicone gel-filled breast implants on Wednesday, allowing Inamed Corp. (IMDC.O: Quote, Profile, Research) to sell its version if it meets certain requirements.
The move puts Inamed on par with rival Mentor Corp. (MNT.N: Quote, Profile, Research) , which received similar approval in July, and signals the impending return of the controversial implants to the U.S. market after a 13-year restriction.
In 1992, the Food and Drug Administration limited sales to breast cancer survivors and others needing reconstruction or implant replacements amid concerns that leaking implants could cause long-term, disabling diseases such as lupus or rheumatoid arthritis.
Analysts said final FDA approval could come by the end of 2005 or the first quarter of 2006.
Jayson Bedford of Adams Harkness Inc. said final approval would add $70 million next year to the overall breast implant market, which is expected to top $400 million.
Wednesday's news sent Inamed shares up $5.95, or 8.4 percent, to $77.01 in late-morning trade on the Nasdaq stock market.
Shares of Medicis Pharmaceutical Corp. (MRX.N: Quote, Profile, Research) , which is buying Inamed, were up $1.40, or 4.3 percent, at $34.05 on the New York Stock Exchange.
CIBC World Markets analyst John Calcagnini said Inamed's approval would boost its profits, but the pending merger could disrupt sales staff. "Mentor continues to gain market share," he added.
Mentor shares fell $2.33, or 4.4 percent, $50.23 on the New York Stock Exchange.
In April, an FDA advisory panel narrowly voted against recommending the lifting of sales restrictions on Inamed's implants but urged approval for similar implants from Mentor.
"Since then, Inamed has provided FDA with additional information to address the primary safety concerns discussed by the panel. Inamed has also said that it will no longer make available Style 153, which raised particular safety issues for the panel," the FDA said in a statement.
Women's groups and other critics have called for more data on how often silicone implants break or leak.
The FDA said federal law prevented it from disclosing the requirements imposed on Inamed as a condition of approval, but the company said they were in line with its expectations and discussions at FDA advisory panel meetings in 2003 and last April. It said it would work with the FDA to address them.
"We respect the thoroughness of the FDA review process and are pleased with this decision," said a statement by Nick Teti, Inamed chairman, president and chief executive.
Recent MRX News
- Marex Group plc to participate in upcoming Barclays Global Financial Services Conference • GlobeNewswire Inc. • 09/06/2024 11:03:17 AM
- Marex Group plc announces 2024 Interim Results • GlobeNewswire Inc. • 08/14/2024 11:00:04 AM
- Marex Group plc Provides Notice of H1 2024 Results and Conference Call • GlobeNewswire Inc. • 07/19/2024 11:00:00 AM
- Marex Collaborates with CoinDesk Indices to Offer Certificates on the CoinDesk 20 Index • PR Newswire (US) • 06/28/2024 11:14:00 AM
- Marex Appoints Liz Barrett as Group Head of HR • GlobeNewswire Inc. • 06/18/2024 02:11:06 PM
- Marex to offer client clearing of interest rate swaps • GlobeNewswire Inc. • 06/17/2024 12:03:07 PM
- Marex Group plc to Participate in Upcoming Piper Sandler Global Exchange & FinTech Conference • GlobeNewswire Inc. • 05/31/2024 06:30:07 PM
- Stifel and Marex Announce Prime Brokerage Referral Partnership • GlobeNewswire Inc. • 05/28/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/16/2024 11:31:18 AM
- Marex Group plc Announces Full Year 2023 Results and Q1 2024 Update • GlobeNewswire Inc. • 05/16/2024 11:10:52 AM
- Marex Group plc to Report FY 2023 Results and Q1 2024 Update on May 16, 2024 • GlobeNewswire Inc. • 05/13/2024 09:40:40 PM
- Marex Group plc Announces Pricing of Initial Public Offering • GlobeNewswire Inc. • 04/25/2024 01:33:37 AM
- Marex Group plc Announces Launch of Initial Public Offering • GlobeNewswire Inc. • 04/15/2024 01:19:28 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM